abstract |
Disclosed is the compound 3-{[5-azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-2-hydroxy-1-methylethyl}oxy}-N--(5-methylpyrazin-2-yl)benzamide, or a salt thereof. Also disclosed is the use of the above compound or a pharmaceutically-acceptable salt thereof, in the preparation of a medicament for treatment of a disease mediated through GLK such as type 2 diabetes. (62) Divided Out of 564608 |